MediciNova announces update on phase 2b trial
Posted: Tue Jun 16, 2015 2:04 am
MediciNova has announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (PMS) has finished the randomisation of 255 patients, exceeding the initial goal of 250 patients........ Read More - http://www.ms-uk.org/MN-166